ECO Animal Health Doc re. Block Listing Admission

 
TIDMEAH 
 
 

ECO Animal Health Group PLC

Block Listing Admission

ECO Animal Health Group PLC (the "Company") announces that an application has been made to the London Stock Exchange for an extension of its existing block listing admission by 1,400,000 ordinary shares of 5 pence each (the "New Ordinary Shares") to be admitted to AIM in connection with the Company's Executive Share Option Scheme and the Unapproved Share Option Scheme (the "Schemes"). These New Ordinary Shares may be issued from time to time pursuant to the exercise of options by employees participating in the Schemes.

When issued, the New Ordinary Shares will rank pari passu in all respects with the existing ordinary shares of the Company. Admission of the New Ordinary Shares is expected to take place on 15 August 2018.

The total number of ordinary shares of 5 pence each in the Company as at the date of this announcement is 66,300,066. There are currently nil shares held in treasury.

The total number of voting rights in the Company is therefore 66,300,066. This figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company, under the Disclosure Guidance and Transparency Rules. The Company will notify on a monthly basis when there are changes to the issued share capital of the Company, and these monthly figures may be used by shareholders as the denominator for the calculation by which they will determine if they are required to notify their interest in, or a change in their interest in, the share capital of the Company.

For further information, please contact:

 
Enquiries 
ECO Animal Health Group plc                       020 8336 6190 
Peter Lawrence, Non-Executive Chairman            020 8447 8899 
Marc Loomes, CEO 
N+1 Singer (Nominated Advisor and Joint Broker)   020 7496 3000 
Mark Taylor 
James White 
Peel Hunt (Joint Broker)                          020 7418 8900 
James Steel 
Dr Christopher Golden 
 
 
 
 

View source version on businesswire.com: https://www.businesswire.com/news/home/20180809005874/en/

 
This information is provided by Business Wire 
 
 

(END) Dow Jones Newswires

August 10, 2018 02:58 ET (06:58 GMT)